
Bain seals $3.36bn deal for Mitsubishi Chemical pharmaceutical unit
Mitsubishi Chemical has agreed to sell its pharmaceutical subsidiary, Mitsubishi Tanabe Pharma, to US private equity firm Bain Capital in a deal valued at JPY510bn ($3.36bn) as part of a broader effort to streamline its portfolio.
